SFE Investment Counsel’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-10,055
| Closed | -$425K | – | 125 |
|
2021
Q4 | $425K | Buy |
10,055
+627
| +7% | +$26.5K | 0.11% | 99 |
|
2021
Q3 | $429K | Buy |
9,428
+63
| +0.7% | +$2.87K | 0.12% | 98 |
|
2021
Q2 | $458K | Buy |
9,365
+399
| +4% | +$19.5K | 0.13% | 95 |
|
2021
Q1 | $451K | Sell |
8,966
-1,869
| -17% | -$94K | 0.13% | 92 |
|
2020
Q4 | $555K | Buy |
10,835
+2,044
| +23% | +$105K | 0.18% | 90 |
|
2020
Q3 | $362K | Buy |
8,791
+66
| +0.8% | +$2.72K | 0.14% | 92 |
|
2020
Q2 | $365K | Sell |
8,725
-829
| -9% | -$34.7K | 0.16% | 85 |
|
2020
Q1 | $303K | Sell |
9,554
-296
| -3% | -$9.39K | 0.17% | 92 |
|
2019
Q4 | $416K | Sell |
9,850
-280
| -3% | -$11.8K | 0.17% | 89 |
|
2019
Q3 | $320K | Buy |
10,130
+520
| +5% | +$16.4K | 0.14% | 99 |
|
2019
Q2 | $347K | Buy |
9,610
+1,826
| +23% | +$65.9K | 0.15% | 97 |
|
2019
Q1 | $282K | Buy |
+7,784
| New | +$282K | 0.13% | 99 |
|